Ubisense's solutions have been found to be a more accurate diagnostic tool than one of the established tests and has outperformed RFID tracking because of its greater accuracy.
The collaboration with the University of South Florida marks its entry into the world of medtech.
Ubisense tools have been used in medical applications before, but only for the purpose of improving equipment availability and utilisation, this is the first time they have been used for therapeutic purposes.
Though Ubisense says the system is only at the development stage and as of yet, still too early to plan a rollout, a spokesperson said that an operational system would have several advantages over current diagnostic methods and rather than be resource intensive because of the sensors and tags required, it would save time and effort and potentially be more accurate.
"Today's methods for testing for dementia are labour intensive, and require interaction from the elder which may skew the results," Ubisense told Cabume.
"The advantage of this system is that it is transparent to the elder, allowing them to act naturally and therefore provide more valid data. The tracking of individuals is automatic, and once the algorithms are perfected they will run in real time without requiring a person in the loop."
The company recently listed on the LSX and will provide its first interim results on 20 September.blog comments powered by Disqus